7 news items
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GRTS
9 May 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
GRTS
29 Apr 24
. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GRTS
8 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GRTS
1 Apr 24
innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we
Gritstone bio Announces Proposed Public Offering
GRTS
1 Apr 24
to train multiple arms of the immune system to attack critical disease targets. Independently and with our collaborators, we are advancing a portfolio
ef5hqk3
GRTS
1 Apr 24
that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack
lnpns
GRTS
5 Mar 24
biotechnology company that aims to develop the world's most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune
- Prev
- 1
- Next